Investment performance

—IPO

603803.SH

IPO in 2017

A leading company providing comprehensive access solutions and network devices

002933.SZ

IPO in 2018

A high-tech company producing combat helicopters electric servo drive system

300079.SZ

IPO in 2010

A worldwide leader of video delivery solutions to broadcast, internet, etc.

300540.SZ

IPO in 2016

A leading company of cryogenic technology research and development

002933.SZ

IPO in 2011

A famous company focusing on regenerative medicine industry

603858.SH

IPO in 2016

A leading company of patented proprietary Chinese medicine

603045.SH

IPO in 2018

A high-tech vendor integrating R&D, production, sales of electrical contact materials

603105.SH

IPO in 2018

A leading company in distributed photovoltaic industry

Investment performance

—Back-door listing

000591.SZ

Back-door listing in 2015

The second largest photovoltaic plant operator in China

002147.SZ

Back-door listing in 2016

A leading company focusing on commercial and tourism real estate development

002027.SZ

Back-door listing in 2016

The largest digital media group in China

601360.SH

Back-door listing in 2018

The biggest provider of Internet and mobile security products

Investment performance

—Strategic investment

002073.SZ

IPO in 2006

A high-tech enterprise group company committed to R&D and innovation of information equipment and software application in rubber industry

Mesnac has grown into a multinational rubber company from a small business with our operation management

A share IPO in October of 2006

投ROI: 150x资收益:150倍

601058.SH

IPO in 2011

A leading rubber tire development and manufacturing company in China

One of our team members was the Sailun’s founder, assisted in completing two rounds of equity financing, helped it grow to one of the leading companies in the field of rubber tires

A share IPO in 2011

ROI: 300%

600572.SH

IPO in 2004

TOP 10traditional Chinese medicine company

Provided professional supporting in acquisitions, and consulting service to help the company grow to be Top 10 Chinese medicine company and the leading pharmaceutical company in Zhejiang province.

Completed A share IPO in 2004

The share price grown more than 1000%

603803.SH

Back door listing in 2006

A leading pharmaceutical company in FSC/DTP model

Provided consulting service and support in acquisitions of pharmaceutical retail chain and FSC/DTP model transformation.

Completed A share IPO in 2006

Built several famous medical brand, like妇炎洁、优卡丹、可立克、闪亮滴眼液

600600.SH/0168.HK

IPO in 1993
The fifth largest beer manufacturer worldwide

Helped Fosun Group and Tsingtao Group close a deal with Asahi Group, the second largest share holder. Fosun and Tsingtao paid HKD 27.22 per share, about 70% of the market price, to purchase shares from Asahi Group. The price increased to HKD 50 per share after the deal.

Our team was in charge of operating, equity incentives, and market policies as well as the brand positioning of Tsingtao Group.

Investment return:over HKD 5.5 billion

IRR: over 200%

300038.SZ

IPO in 2010
The second largest SSP plateform worldwide

Provided service of asset valuation and M&A to help Shuzhi Company to acquire 66.67% shares of BBHI with RMB 6.3 billion. This M&A deal helped Shuzhi Company expand the business to the entire supply chain.

The revenue of Shuzhi Company increased 100% in both 2017 and 2018.

IPO in Lima Exchange

TOP 4 insurance company in Peru

Our team worked with Fidelidade Insurance Company, the largest insurance company in Portugal controlled by Fosun Group, and led the Fidelidade’s acquisition of Peruvian LA Positiva insurance company by providing consulting and executive level communication services. This acquisition helped Fosun Group expand its business from Europe to Latin American market

Market value: PEN 425 million

Over 15 years in pan- Europe alternative asset investment

Provided service of asset valuation and M&A to assist Hongkong Fosun Capital Company to acquire 75% shares of Tenax Capital Limited. Fosun is qualified for the pan-Europe alternative asset investment and global asset management after this acquisition.

Fund scale: EUR 1 Billion